One thing is clear to me that the management wouldn't spend another loads of money to get the FDA discussion & approval if they thought they didn't have a case. If they didn't have faith in their data they wouldn't walk on a suicidal path - not the third time! Next disapproval from the FDA will certainly finish MSB, so they must have thought it theough and consulted scientists before the announcement.
I have a feeling that this time it gonna go through so I just gonna sit tight. I dont mind bit of fluctuations here n there, P&Ds will keep playing their hands, they dont care about company performance, they just want to make bucks along the way.
Cheers
Commo
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-381
-
- There are more pages in this discussion • 383 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
-0.025(1.86%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.35 | $1.31 | $2.699M | 2.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34995 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 10374 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |